PDL’s Terlipressin Fails Phase III Trial; Company To Meet With FDA
Late-stage development compound was evaluated for treatment of type 1 hepatorenal syndrome.
Late-stage development compound was evaluated for treatment of type 1 hepatorenal syndrome.